{
  "company": "IQVIA Holdings",
  "ticker": "IQV",
  "period": {
    "from": "2026-03-27",
    "to": "2026-04-26",
    "days": 30
  },
  "sentiment_breakdown": {
    "positive": 14,
    "negative": 1,
    "neutral": 3
  },
  "synthesis": {
    "executive_summary": "Sentiment analysis for IQVIA Holdings (IQV) from 2026-03-27 to 2026-04-26. Analyzed 18 items across FDA and news sources.",
    "key_findings": [],
    "overall_sentiment": "neutral"
  },
  "top_positive": [
    {
      "title": "AI-Powered Clinical Trial Site Feasibility Research Report 2026: $4.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
      "date": "2026-04-24",
      "source": "news",
      "score": 1.0
    },
    {
      "title": "$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics",
      "date": "2026-04-09",
      "source": "news",
      "score": 0.943
    },
    {
      "title": "Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F",
      "date": "2026-04-24",
      "source": "news",
      "score": 0.912
    },
    {
      "title": "Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
      "date": "2026-04-14",
      "source": "news",
      "score": 0.898
    },
    {
      "title": "AI in Clinical Trials Research Report 2026: $54.71 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
      "date": "2026-04-24",
      "source": "news",
      "score": 0.888
    },
    {
      "title": "Real World Evidence Solutions Research Report 2026: $4.81 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
      "date": "2026-04-24",
      "source": "news",
      "score": 0.886
    },
    {
      "title": "AI-Based Clinical Trial Solution Providers Research Report 2026: $8.5+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
      "date": "2026-04-24",
      "source": "news",
      "score": 0.886
    },
    {
      "title": "Rare Disease Clinical Trials Research Report 2026: $21.34 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
      "date": "2026-04-24",
      "source": "news",
      "score": 0.878
    },
    {
      "title": "Early Phase Clinical Trial Outsourcing Research Report 2026: $14.8 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
      "date": "2026-04-24",
      "source": "news",
      "score": 0.875
    },
    {
      "title": "Mobile Health (mHealth) Adverse-Event Reporting Apps Analysis Report 2026: $4.27 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
      "date": "2026-04-24",
      "source": "news",
      "score": 0.869
    }
  ],
  "top_negative": [
    {
      "title": "IQVIA Holdings (IQV) Traded Lower Due to AI-Related Fears Despite Reporting In-Line Results",
      "date": "2026-04-15",
      "source": "news",
      "score": -0.612
    }
  ],
  "raw_data": {
    "total_items": 18,
    "items": [
      {
        "source": "sec",
        "filing_type": "8-K",
        "title": "8-K  - Current report",
        "date": "2026-04-23",
        "url": "https://www.sec.gov/Archives/edgar/data/1478242/000119312526173771/0001193125-26-173771-index.htm",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F",
        "description": "Key market opportunities include the rising demand for AI-enhanced trial design, boosted by increasing complexity in clinical trials, precision medicine focus, predictive analytics, and decentralized designs. Growth is driven by advancements in genomic sequen…",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280628/28124/en/Artificial-Intelligence-Clinical-Trial-Protocol-Feasibility-Tool-Research-Report-2026-2-75-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T09:54:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.912,
          "confidence": 0.91
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Mobile Health (mHealth) Adverse-Event Reporting Apps Analysis Report 2026: $4.27 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "Key market opportunities in the mHealth adverse-event reporting apps sector include the rise of AI-driven safety analytics, increased remote patient monitoring, and smartphone penetration. Integration with electronic health records and regulatory-compliant to…",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280623/28124/en/Mobile-Health-mHealth-Adverse-Event-Reporting-Apps-Analysis-Report-2026-4-27-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T09:45:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.869,
          "confidence": 0.87
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Real World Evidence Solutions Research Report 2026: $4.81 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "Key opportunities in the real-world evidence solutions market include integration of AI and advanced analytics, precision medicine expansion, and geriatric population growth. Rising demand for post-approval evidence and regulatory decision-making drive market…",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280614/28124/en/Real-World-Evidence-Solutions-Research-Report-2026-4-81-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T09:18:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.886,
          "confidence": 0.89
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "AI in Clinical Trials Research Report 2026: $54.71 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "Key market opportunities include the rise of AI-driven patient recruitment, predictive trial outcome modeling, and automated data analysis in clinical trials. Growth is fueled by decentralized trial expansions, regulatory acceptance of AI, precision medicine …",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280612/28124/en/AI-in-Clinical-Trials-Research-Report-2026-54-71-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T09:17:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.888,
          "confidence": 0.89
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Early Phase Clinical Trial Outsourcing Research Report 2026: $14.8 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "The early phase clinical trial outsourcing market presents opportunities driven by rising personalized medicine focus, decentralized trials, and regulatory harmonization. Increasing biotech activity and AI-enabled analytics boost demand for specialized CROs. …",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280610/28124/en/Early-Phase-Clinical-Trial-Outsourcing-Research-Report-2026-14-8-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T09:07:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.875,
          "confidence": 0.88
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "AI-Powered Clinical Trial Site Feasibility Research Report 2026: $4.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "The AI-powered clinical trial site feasibility market is poised for strong growth, fueled by rising complexity in trial designs, demand for data-driven planning, and expansion of global trials. Key opportunities include adopting AI-driven site selection model…",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280609/28124/en/AI-Powered-Clinical-Trial-Site-Feasibility-Research-Report-2026-4-38-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T09:05:00Z",
        "sentiment": {
          "label": "positive",
          "score": 1.0,
          "confidence": 1.0
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Decentralized Clinical Trials Research Report 2026: $19.55 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "Key market opportunities in decentralized clinical trials include increased adoption of hybrid trial designs, AI-driven optimization, and virtual trial platforms driven by telemedicine and digital health expansions. This enhances patient recruitment efficienc…",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280606/28124/en/Decentralized-Clinical-Trials-Research-Report-2026-19-55-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T09:02:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.863,
          "confidence": 0.86
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Rare Disease Clinical Trials Research Report 2026: $21.34 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "Key opportunities in the rare disease clinical trials market include expanding orphan drug programs, adopting virtual/hybrid trials, leveraging AI for optimization, decentralized trial models, and personalized medicine focus. Growth is driven by enhanced coll…",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280605/28124/en/Rare-Disease-Clinical-Trials-Research-Report-2026-21-34-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T09:01:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.878,
          "confidence": 0.88
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Mental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "Key market opportunities in mental health clinical trials include the rise of digital interventions, personalized psychiatry research, decentralized trials, and AI-driven patient recruitment. This is fueled by growing mental health disorder prevalence and reg…",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280602/28124/en/Mental-Health-Clinical-Trials-Research-Report-2026-4-89-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T08:57:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.599,
          "confidence": 0.6
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "AI-Based Clinical Trial Solution Providers Research Report 2026: $8.5+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "Key market opportunities include leveraging AI to optimize patient recruitment, enhance trial predictions, and streamline clinical operations. The rise of cloud-based and decentralized trial platforms, coupled with AI-driven data analytics and automation, dri…",
        "url": "https://www.globenewswire.com/news-release/2026/04/24/3280599/28124/en/AI-Based-Clinical-Trial-Solution-Providers-Research-Report-2026-8-5-Bn-Market-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-24",
        "published_at": "2026-04-24T08:52:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.886,
          "confidence": 0.89
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "IQVIA Holdings (IQV) Traded Lower Due to AI-Related Fears Despite Reporting In-Line Results",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_c44e19f9-3cbc-418d-9410-73cda22da63e",
        "date": "2026-04-15",
        "published_at": "2026-04-15T13:47:59Z",
        "sentiment": {
          "label": "negative",
          "score": -0.612,
          "confidence": 0.61
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "IQVIA Holdings Earnings Preview: What to Expect",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_7a015b60-c723-4986-abbb-957eeac0b01e",
        "date": "2026-04-15",
        "published_at": "2026-04-15T10:49:35Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F",
        "description": "The drug development services market presents significant opportunities due to the rise in R&D investments, AI adoption, personalized medicine, and emerging markets. Growth areas include preclinical research, regulatory optimization, and cloud-based data mana…",
        "url": "https://www.globenewswire.com/news-release/2026/04/14/3273662/28124/en/Drug-Development-Services-Market-Research-Report-2026-50-Bn-Opportunities-Trends-Competitive-Landscape-Strategies-and-Forecasts-2020-2025-2025-2030F-2035F.html",
        "date": "2026-04-14",
        "published_at": "2026-04-14T14:59:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.898,
          "confidence": 0.9
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics",
        "description": "The biopharmaceutical CXO market offers opportunities in strategic outsourcing, digital integration, resilient supply chains, and value-driven partnerships amidst evolving regulatory landscapes. The biopharmaceutical CXO market offers opportunities in strateg…",
        "url": "https://www.globenewswire.com/news-release/2026/04/09/3270735/28124/en/1-05-Bn-Biopharmaceutical-CXO-Markets-Global-Forecast-Report-2026-2032-How-Leading-Pharmas-Such-as-Pfizer-Roche-Novartis-Sanofi-and-AstraZeneca-Navigate-the-Evolving-Dynamics.html",
        "date": "2026-04-09",
        "published_at": "2026-04-09T10:05:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.943,
          "confidence": 0.94
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "IQVIA Holdings Inc. (IQV): Billionaire David Tepper Makes Minor Adjustment",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_aca927a4-f5a6-41e8-a121-330b5bf66fde",
        "date": "2026-04-07",
        "published_at": "2026-04-07T14:28:03Z",
        "sentiment": {
          "label": "neutral",
          "score": 0.0,
          "confidence": 0.0
        }
      },
      {
        "source": "news",
        "source_name": "GlobeNewswire",
        "title": "Dermatomyositis Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status",
        "description": "The clinical trial report highlights opportunities in Dermatomyositis trials by revealing key trends in trial phases, sponsor types, and regions, particularly in G7 and E7 countries. It aids strategic decision-making by identifying prime trial locations and o…",
        "url": "https://www.globenewswire.com/news-release/2026/04/07/3269299/28124/en/Dermatomyositis-Global-Clinical-Trials-Market-Review-Report-2026-Region-Country-G7-E7-Trial-Status-Trial-Phase-Sponsor-Type-and-End-Point-Status.html",
        "date": "2026-04-07",
        "published_at": "2026-04-07T13:28:00Z",
        "sentiment": {
          "label": "positive",
          "score": 0.382,
          "confidence": 0.38
        }
      },
      {
        "source": "news",
        "source_name": "Yahoo Entertainment",
        "title": "IQVIA (IQV) Launches IQVIA.ai Unified Agentic AI Platform with Nvidia",
        "description": "",
        "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_14b688ee-99d8-45eb-830b-c9df2dca0d5d",
        "date": "2026-04-05",
        "published_at": "2026-04-05T18:31:21Z",
        "sentiment": {
          "label": "positive",
          "score": 0.382,
          "confidence": 0.38
        }
      }
    ]
  }
}